The Liver and the Brain
Authors: J. M. WALSHE
Journal: Annals of Internal Medicine (1961)

Editorials1 November 1961The Liver and the BrainJ. M. WALSHEJ. M. WALSHESearch for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-55-5-867 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptThe nature of the relationship between the liver and the brain is one of the oldest problems in medicine and one that has proved a fruitful source of speculation from the time of Hippocrates to the present day. Space does not permit an historical review of the extensive literature on this subject, nor does the situation require it. It is only in recent years that theory has been replaced by knowledge based on the scientific study of disease. Until scarcely two decades ago the question which bedeviled most writers was the nature and locus of the primary abnormality: Should this...References1. GREENFIELD JG: Is hepatolenticular degeneration a clinico-pathological entity? Proc. Roy. Soc. Med. 47: 150, 1954. CrossrefMedlineGoogle Scholar2. BROWN IA: Liver-Brain Relationships, Charles C Thomas, Springfield, 1957. Google Scholar3. BARONDENTHARRISHARTJEPSON DNCEHEWJB: Hereditary pellagra-like skin rash with temporary cerebellar ataxia, constant renal amino-aciduria and other bizarre biochemical features. Lancet 2: 421, 1956. CrossrefGoogle Scholar4. JEPSON JB: Indolylacetyl-glutamine and other indole metabolites in Hartnup disease. Biochem. J. 64: 14P, 1950. Google Scholar5. ALLANCUSWORTHDENTWILSON JDDCCEVI: A disease, probably hereditary, characterised by severe mental deficiency and a constant gross abnormality of aminoacid metabolism. Lancet 1: 182, 1958. CrossrefMedlineGoogle Scholar6. WESTALLDANCISLEVITZMILLER RGJMS: Maple sugar urine disease. Fed. Proc. 17: 334, 1958. Google Scholar7. COCHRANE W: Idiopathic infantile hypoglycemia and leucine sensitivity. Metabolism 9: 386, 1960. MedlineGoogle Scholar8. FROESCHPRADERLABHARTSTUBERWOLF ERAAHWHP: Hereditary fructose intolerance, a congenital metabolic disorder unknown until now. Schweiz. Med. Wschr. 87: 1168, 1957. MedlineGoogle Scholar9. HARRIS H: Human Biochemical Genetics, Cambridge University Press, 1959. Google Scholar10. BILLINGLATHE BHGH: Bilirubin metabolism in jaundice. Amer. J. Med. 24: 111, 1958. CrossrefMedlineGoogle Scholar11. CRIGLERNAJJAR JFVA: Congenital familial nonhemolytic jaundice with kernicterus. Pediatrics 10: 169, 1952. MedlineGoogle Scholar12. SCHMID R: Congenital defects in bilirubin metabolism. J. Clin. Invest. 36: 927, 1957. Google Scholar13. GUNN CK: Hereditary acholuric jaundice in rat: defect of bilirubin conjugation. Canad. Med. Ass. J. 50: 230, 1944. MedlineGoogle Scholar14. JERVIS GA: Studies on phenylpyruvic oligophrenia. J. Biol. Chem. 169: 651, 1947. CrossrefMedlineGoogle Scholar15. JERVIS GA: Phenylpyruvic oligophrenia: deficiency of phenylalanine-oxidizing system. Proc. Soc. Exp. Biol. Med. 82: 514, 1953. MedlineGoogle Scholar16. BESSMANTADA SPK: Indicanuria in phenylketonuria. Metabolism 9: 377, 1960. MedlineGoogle Scholar17. WATSON CJ: The problem of porphyria—some facts and questions. New Engl. J. Med. 263: 1205, 1960. CrossrefMedlineGoogle Scholar18. WALDENSTRÖM J: Studien uber porphyrie. Acta Med. Scand. Suppl. 82: 1937. Google Scholar19. GRANICKSCHREICK SHG: Porphobilinogen and δ-aminolevulinic acid in acute porphyria. Proc. Soc. Exp. Biol. Med. 88: 270, 1955. CrossrefMedlineGoogle Scholar20. GOLDBERGPATONTHOMPSON AWDJW: Pharmacology of the porphyrins and porphobilinogen. Brit. J. Pharmacol. 9: 91, 1954. Google Scholar21. SCHWARZGOLDBERGKOMROWERHOLZEL VLGMA: Some disturbances of erythrocyte metabolism in galactosaemia. Biochem. J. 62: 34, 1956. CrossrefMedlineGoogle Scholar22. HOLMBERG CG: in Wilson's Disease, Some Current Concepts, ed. by Walshe, J. M., and Cumings, J. W., Blackwell Scientific Publications, Oxford, 1961. Google Scholar23. DAVISPETERSWALSHE ARAJM: The effect of sub-arachnoid injections of the Cu++ in pigeons. J. Physiol. To be published. Google Scholar24. RICHTERICH R: in Wilson's Disease, Some Current Concepts, ed. by Walshe, J. M., and Cumings, J. N., Blackwell Scientific Publications, Oxford, 1961. Google Scholar25. MORELLSHAPIROSCHEINBERG AGJRIH: in Wilson's Disease, Some Current Concepts, ed. by Walshe, J. M., and Cumings, J. N., Blackwell Scientific Publications, Oxford, 1961. Google Scholar26. WalsheCumings JMJN Wilson's Disease, Some Current Concepts, ed. by , Blackwell Scientific Publications, Oxford, 1961. Google Scholar27. WALSHEBRIGGS JMJ: Unpublished observations. Google Scholar28. WALSHE JM: in Lectures on the Scientific Basis of Medicine, Vol. VIII, The Athlone Press, University of London, 1958-9. Google Scholar29. BROMBERGROBINFORKNER PAEDCE: The existence of ammonia in blood with observations on the significance of the NH4 +-NH3 system. J. Clin. Invest. 39: 332, 1960. CrossrefMedlineGoogle Scholar30. BESSMANFAZEKASBESSMAN SPJFAN: Uptake of ammonia by the brain in hepatic coma. Proc. Soc. Exp. Biol. Med. 85: 66, 1954. CrossrefMedlineGoogle Scholar31. TYORWILSON MPWP: Peripheral biochemical changes associated with the intravenous administration of ammonium salts in normal subjects. J. Lab. Clin. Med. 51: 592, 1958. MedlineGoogle Scholar32. WALSHEDECARLIDAVIDSON JMLCS: Some factors influencing cerebral oxidation in relation to hepatic coma. Clin. Sci. 17: 11, 1958. MedlineGoogle Scholar33. WALSHEDECARLIDAVIDSON JMLCS: Some factors influencing cerebral ammonia production in relation to hepatic coma. Clin. Sci. 17: 27, 1958. MedlineGoogle Scholar34. BORGESMERLISBESSMAN FJJKSP: Serotonin metabolism in liver disease. J. Clin. Invest. 38: 715, 1959. CrossrefMedlineGoogle Scholar35. CHALLENGERWALSHE FJM: Foetor hepaticus. Lancet 1: 1239, 1955. CrossrefGoogle Scholar36. WARRENNATHAN KSDG: The passage of ammonia across the blood-brain-barrier and its relation to blood pH. J. Clin. Invest. 37: 1724, 1958. CrossrefMedlineGoogle Scholar37. WARREN KS: The differential toxicity of ammonium salts. J. Clin. Invest. 37: 497, 1958. CrossrefMedlineGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: Department of Experimental Medicine University of Cambridge England PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited ByReactivity of 3-(benzothiazol-2-yl)-3-oxopropanenitrile: A facile synthesis of novel polysubstituted thiophenesNicotinic Acid in the Prevention and Treatment of Methionine-Induced Exacerbation of Psychopathology in Schizophrenics 1 November 1961Volume 55, Issue 5Page: 867-872KeywordsBrainLiver Issue Published: 1 November 1961 PDF DownloadLoading ...